224 related articles for article (PubMed ID: 9427648)
21. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
[TBL] [Abstract][Full Text] [Related]
22. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
Zhu S; Zhang H; Matunis MJ
Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
[TBL] [Abstract][Full Text] [Related]
23. T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.
He Y; Yang Z; Zhao CS; Xiao Z; Gong Y; Li YY; Chen Y; Du Y; Feng D; Altman A; Li Y
Elife; 2021 Jun; 10():. PubMed ID: 34110283
[TBL] [Abstract][Full Text] [Related]
24. Identification of a substrate recognition site on Ubc9.
Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
[TBL] [Abstract][Full Text] [Related]
25. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
[TBL] [Abstract][Full Text] [Related]
26. The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo.
Joseph J; Liu ST; Jablonski SA; Yen TJ; Dasso M
Curr Biol; 2004 Apr; 14(7):611-7. PubMed ID: 15062103
[TBL] [Abstract][Full Text] [Related]
27. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
[TBL] [Abstract][Full Text] [Related]
28. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
[TBL] [Abstract][Full Text] [Related]
29. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
Desterro JM; Rodriguez MS; Kemp GD; Hay RT
J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
[TBL] [Abstract][Full Text] [Related]
30. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
[TBL] [Abstract][Full Text] [Related]
31. Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.
Patil H; Yoon D; Bhowmick R; Cai Y; Cho KI; Ferreira PA
Small GTPases; 2019 Mar; 10(2):146-161. PubMed ID: 28877029
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Ahn JH; Xu Y; Jang WJ; Matunis MJ; Hayward GS
J Virol; 2001 Apr; 75(8):3859-72. PubMed ID: 11264375
[TBL] [Abstract][Full Text] [Related]
33. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
Sommer S; Ritterhoff T; Melchior F; Mootz HD
Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
[TBL] [Abstract][Full Text] [Related]
34. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.
Matunis MJ; Coutavas E; Blobel G
J Cell Biol; 1996 Dec; 135(6 Pt 1):1457-70. PubMed ID: 8978815
[TBL] [Abstract][Full Text] [Related]
35. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
Giraud MF; Desterro JM; Naismith JH
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
[TBL] [Abstract][Full Text] [Related]
36. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.
Gong L; Kamitani T; Fujise K; Caskey LS; Yeh ET
J Biol Chem; 1997 Nov; 272(45):28198-201. PubMed ID: 9353268
[TBL] [Abstract][Full Text] [Related]
37. RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
Swaminathan S; Kiendl F; Körner R; Lupetti R; Hengst L; Melchior F
J Cell Biol; 2004 Mar; 164(7):965-71. PubMed ID: 15037602
[TBL] [Abstract][Full Text] [Related]
38. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.
Zhang H; Saitoh H; Matunis MJ
Mol Cell Biol; 2002 Sep; 22(18):6498-508. PubMed ID: 12192048
[TBL] [Abstract][Full Text] [Related]
39. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
[TBL] [Abstract][Full Text] [Related]
40. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
Kurtzman AL; Schechter N
Proc Natl Acad Sci U S A; 2001 May; 98(10):5602-7. PubMed ID: 11331779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
